High apolipoprotein M serum levels correlate with chronic obstructive pulmonary disease

被引:23
作者
Li, Hui [1 ]
Liu, Yinyin [1 ]
Wang, Ling [1 ]
Shen, Ting [1 ]
Du, Wenhan [1 ]
Liu, Zhijun [2 ]
Chen, Ruohong [1 ]
Hu, Min [1 ]
机构
[1] Ctr South Univ, Xiangya Hosp 2, Dept Clin Lab, Changsha 410011, Hunan, Peoples R China
[2] Ctr South Univ, Xiangya Hosp 2, Dept Pulm Med, Changsha 410011, Hunan, Peoples R China
关键词
Apolipoprotein M; Chronic obstructive pulmonary disease; Forced expiratory volume in one second; % predicted FEV1; Cardiovascular disease; LOW-DENSITY-LIPOPROTEIN; PLATELET-ACTIVATING-FACTOR; OXIDIZED PHOSPHOLIPIDS; LUNG-FUNCTION; CHOLESTEROL; ATHEROSCLEROSIS; INFECTION; HDL; EXPRESSION; RECEPTOR;
D O I
10.1186/s12944-016-0228-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Recently, variations in a component of high-density lipoprotein (HDL), namely apolipoprotein M (apoM), were found to be associated with chronic obstructive pulmonary disease (COPD). The aim of this study was to evaluate the association between apoM and COPD severity. Factors associated with apoM, COPD, or coronary artery disease (CAD) were also assessed. Methods: A total of 110 COPD patients and 110 age-and sex-matched non-COPD controls were included. Among them, thirty COPD patients and seven non-COPD controls had CAD. ApoM and pentraxin-3 levels were measured by ELISA. Additionally, the levels of high-sensitivity C-reactive protein (hs-CRP), cholesterol, and triglyceride were assessed using an automatic biochemical analyzer. Results: Serum apoM levels increased gradually with COPD severity, with the most prominent apoM elevation observed in very severe COPD cases. In addition, ApoM was correlated with percent-predicted forced expiratory volume in one second (% predicted FEV1) (r = -0.38, P < 0.001), low-density lipoprotein cholesterol (LDL-C) (r = 0.23, P < 0.017), and hs-CRP (r = 0.24, P = 0.01) in COPD patients. Furthermore, apoM was shown to be a risk factor for COPD onset (OR = 1.095, 95 % CI = 1.034-1.160, P = 0.002), but not associated with CAD in COPD patients. Conclusions: Serum apoM was elevated in COPD patients and increased gradually with COPD severity. However, there was no association between apoM and CAD development in COPD patients.
引用
收藏
页数:7
相关论文
共 40 条
[1]   The Apolipoprotein M-Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis [J].
Arkensteijn, Bas W. C. ;
Berbee, Jimmy F. P. ;
Rensen, Patrick C. N. ;
Nielsen, Lars B. ;
Christoffersen, Christina .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (03) :4419-4431
[2]   High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A ;
Huang, YD .
ATHEROSCLEROSIS, 1996, 124 :S11-S20
[3]   HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation [J].
Blaho, Victoria A. ;
Galvani, Sylvain ;
Engelbrecht, Eric ;
Liu, Catherine ;
Swendeman, Steven L. ;
Kono, Mari ;
Proia, Richard L. ;
Steinman, Lawrence ;
Han, May H. ;
Hla, Timothy .
NATURE, 2015, 523 (7560) :342-+
[4]   APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema [J].
Burkart, Kristin M. ;
Manichaikul, Ani ;
Wilk, Jemma B. ;
Ahmed, Firas S. ;
Burke, Gregory L. ;
Enright, Paul ;
Hansel, Nadia N. ;
Haynes, Demondes ;
Heckbert, Susan R. ;
Hoffman, Eric A. ;
Kaufman, Joel D. ;
Kurai, Jun ;
Loehr, Laura ;
London, Stephanie J. ;
Meng, Yang ;
O'Connor, George T. ;
Oelsner, Elizabeth ;
Petrini, Marcy ;
Pottinger, Tess D. ;
Powell, Charles A. ;
Redline, Susan ;
Rotter, Jerome I. ;
Smith, Lewis J. ;
Artigas, Maria Soler ;
Tobin, Martin D. ;
Tsai, Michael Y. ;
Watson, Karol ;
White, Wendy ;
Young, Taylor R. ;
Rich, Stephen S. ;
Barr, R. Graham .
EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (04) :1003-1017
[5]  
Cardenas GA, 2008, REV CARDIOVASC MED, V9, P239
[6]   SUSCEPTIBILITY OF SMALL, DENSE, LOW-DENSITY LIPOPROTEINS TO OXIDATIVE MODIFICATION IN SUBJECTS WITH THE ATHEROGENIC LIPOPROTEIN PHENOTYPE, PATTERN-B [J].
CHAIT, A ;
BRAZG, RL ;
TRIBBLE, DL ;
KRAUSS, RM .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04) :350-356
[7]   The signal peptide anchors apolipoprotein m in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma [J].
Christoffersen, Christina ;
Ahnstrom, Josefin ;
Axler, Olof ;
Christensen, Erik Ilso ;
Dahlback, Bjorn ;
Nielsen, Lars Bo .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (27) :18765-18772
[8]   Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice [J].
Christoffersen, Christina ;
Jauhiainen, Matti ;
Moser, Markus ;
Porse, Bo ;
Ehnholm, Christian ;
Boesl, Michael ;
Dahlback, Bjorn ;
Nielsen, Lars Bo .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (04) :1839-1847
[9]   Isolation and characterization of human apolipoprotein M-containing lipoproteins [J].
Christoffersen, Christina ;
Nielsen, Lars Bo ;
Axler, Olof ;
Andersson, Astra ;
Johnsen, Anders H. ;
Dahlback, Bjorn .
JOURNAL OF LIPID RESEARCH, 2006, 47 (08) :1833-1843
[10]   Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M [J].
Christoffersen, Christina ;
Obinata, Hideru ;
Kumaraswamy, Sunil B. ;
Galvani, Sylvain ;
Ahnstrom, Josefin ;
Sevvana, Madhumati ;
Egerer-Sieber, Claudia ;
Muller, Yves A. ;
Hla, Timothy ;
Nielsen, Lars B. ;
Dahlback, Bjorn .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (23) :9613-9618